**Diabetes Update and Advances in Endocrinology and Metabolism 2027

Thursday, March 18, 2027, 8:00 AM - Saturday, March 20, 2027, 5:15 PM, The Omni San Francisco, San Francisco, CA


AMA PRA Category 1 Credits™ (18.25 hours), ABIM MOC Part 2 (18.25 hours), Accreditation Council for Pharmacy Education (ACPE) CE Credits (18.25 hours), American Academy of Physician Assistants (AAPA) Category 1 CME (18.25 hours), American Nursing Credentialing Center (ANCC) CE Credits (18.25 hours), Geriatric Credits - California Mandated (CA AB 1820) (18.25 hours), Non-Physician Attendance (18.25 hours), Nursing Pharmacotherapeutic Credits (18.25 hours)

The Diabetes Update section on Thursday focuses on new ideas and therapies relevant to patients with Type 1 and Type 2 diabetes. Advances in Endocrinology and Metabolism on Friday and Saturday will provide the clinician with updated, pragmatic information about the management of common endocrinologic and metabolic problems, as well as insight into important current areas in clinical research. Formal presentations will be accompanied by question and answer periods with general discussion. Clinical cases will focus on common endocrine problems encountered in clinical practice.

1. DIABETES UPDATE At the completion of this program, course participants will be able to: • Evaluate and appropriately use GLP-1 receptor agonist therapies and SGLT2 inhibitors, incorporating current evidence regarding indications, benefits, long-term clinical outcomes, patient selection, and the prevention and management of adverse effects.
2. Apply GLP-1 receptor agonist therapy in complex and special patient populations, including patients with type 1 diabetes, solid-organ transplants, cardiovascular disease, end-stage kidney disease, and polycystic ovary syndrome, when clinically appropriate.
3. Evaluate advances in automated insulin delivery systems and identify appropriate candidates for insulin pump and automated insulin delivery therapy.
4. Recognize medications associated with drug-induced diabetes and hyperglycemia and develop appropriate strategies for monitoring and glycemic management.
5. Screen patients at risk for metabolic dysfunction-associated steatotic liver disease (MASLD) and incorporate current approaches to evaluation and treatment into clinical practice.
6. Identify and address emotional and behavioral barriers associated with the diagnosis and treatment of diabetes to support patient engagement, self-management, and achievement of individualized treatment goals.
7. Apply evidence-based approaches to inpatient diabetes management, including the assessment and treatment of hyperglycemia in hospitalized patients.
8. Apply current evidence to the evaluation and management of osteoporosis, including appropriate selection and sequencing of antiresorptive and anabolic therapies.
9. Recognize common causes of low bone density and fragility fractures in women of reproductive age and develop appropriate diagnostic and management strategies.
10. Evaluate patients with hypoparathyroidism and apply current and emerging treatment approaches, including consideration of genetic etiologies when appropriate.
11. Determine the appropriate diagnostic and therapeutic use of radioactive iodine in benign thyroid disorders and thyroid cancer, including the role of diagnostic and post therapy scans, dosimetry and selective use of I-124 imaging.
12. Apply evidence-based approaches to the diagnosis and treatment of hypothyroidism and distinguish established clinical evidence from common misconceptions regarding biochemical evaluation and thyroid hormone replacement.
13. Identify patients with thyroid disorders who may benefit from interventional procedures and appropriately incorporate image-guided and other interventional approaches into multidisciplinary thyroid care.
14. Apply clinical reasoning to the evaluation and management of challenging thyroid cases, integrating laboratory findings, imaging, pathology, and patient-specific considerations.
15. Evaluate adrenal incidentalomas for mild autonomous cortisol secretion and determine appropriate management and follow-up.
16. Evaluate pituitary adenomas and select appropriate medical treatment and monitoring strategies based on tumor type and clinical presentation.
17. Apply current lipid guidelines to cardiovascular risk assessment, screening, treatment targets, and management of patients with lipid disorders.
18. Evaluate the role of newer lipid-lowering therapies and select appropriate agents based on clinical indications, treatment goals, efficacy, safety, and patient-specific factors.

Course Number: MDM27E01

UCSF has transitioned to a new attendee and course portal called CloudCME for all courses happening in 2026 onwards. An account in the UCSF CE Portal is required to register. Click SIGN IN in the menu bar and enter your email address or UCSF MyAccess credentials to complete your profile and continue with registration. Your profile must include your degree and profession to be able to claim credit.

Registration Fees

Registration Category	Fee Before 02/01/2027	Fee After 02/01/2027
Physicians (Full Course)	$650	$685
Physicians (Diabetes Only 03/18/2027)	$400	$435
Physicians (Endo Only 03/19/2027 - 03/20/2027)	$500	$535
Nurses/APPs/Other Health Care Professionals (Full Course)	$450	$485
Nurses/APPs/Other Health Care Professionals (Diabetes Only 03/18/2027)	$300	$335
Nurses/APPs/Other Health Care Professionals (Endo Only 03/19/2027 - 03/20/2027)	$350	$385
Residents/Fellows (Full Course)	$350	$400
Residents/Fellows (Diabetes Only 03/18/2027)	$200	$250
Residents/Fellows (Endo Only 03/19/2027 - 03/20/2027)	$300	$350
Industry	$700	$700

 

---

Additional Fees or Information:

Registration will close on 03/20/2027 at 12:00PM (Noon) Pacific Time.  

Pre-course instructions will be shared with paid registrants 1 week prior to the course.

---

In support of improving patient care, the University of California, San Francisco Office of CME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

---

Cancellation Policy
Cancellations received in writing at least 30 days before the conference start date will receive a refund of registration fees minus a [10%] administrative fee. Requests received between 30 days and 14 days before the start date will receive a 50% refund. No refunds will be issued within 14 days of the start date. Please send cancellation requests through our Refund Request form.
 
UCSF Office of CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets, hotel penalties, or other related personal expenses.

---

Accessibility Statement
UCSF welcomes all participants to our events. If you need a reasonable accommodation to participate in this event because of a disability, please submit a learner support ticket as soon as possible.

---

UCSF Land Acknowledgment Statement
We would like to acknowledge the Ramaytush Ohlone people, who are the traditional custodians of this land. We pay our respects to the Ramaytush Ohlone elders, past, present, and future, who call this place, the land that UCSF sits upon, their home. We are proud to continue their tradition of coming together and growing as a community. We thank the Ramaytush Ohlone community for their stewardship and support, and we look forward to strengthening our ties as we continue our relationship of mutual respect and understanding.

For more information, visit https://opportunity.ucsf.edu/initiatives/ucsf-land-acknowledgment.

Same great education, exciting new location for 2027 -

JOIN US IN THE SPRING AT THE OMNI HOTEL!

We’ve secured a special discounted group rate at the conference hotel for our attendees. Be sure to book your room early—reservations must be made by the cut-off date or before the block is sold out. After the cut-off date, or if the room block sells out, rooms will be subject to availability and the group rate cannot be guaranteed.

By staying at the host hotel, you help UCSF meet its contractual obligations and keep registration fees reasonable.

Hotel Name: Omni Hotel San Francisco

Hotel Address: 500 California St, San Francisco, CA 94104

Hotel Phone Number: (415) 677-9494

Hotel Website: https://www.omnihotels.com/hotels/san-francisco 

Room Rate: $285.00/night + taxes and fees

Cutoff Date: Wednesday, February 24, 2027

Link to Room Block Reservations: https://bookings.omnihotels.com/event/san-francisco/UCSF-Diabetes-and-Endocrinology-Update

Additional Information for Rooms Booked Within the Conference Room Block:

• Waived destination fee (regularly $35/night); destination fee inclusions will apply

• Complimentary premium guestroom Wi-Fi access

• Complimentary use of the hotel's fitness center

Explore the Omni San Francisco Hotel

Access Photo Gallery

Take a Virtual Tour

---

Air Travel

United Airlines

We are pleased to partner with United Airlines® for travel to our upcoming event.

• To make flight reservations online please enter discount code ZRMC505963

• MileagePlus® members earn miles for their travel when using the United Meetings? discount code.

You may also call United Meetings Reservation Desk from 7 a.m. to 8 p.m. CT, Monday–Friday (closed for major U.S. holidays) at (800) 426-1122 for booking assistance or visit united.com/meetingtravel and enter the code above.

Booking fees are waived for United Meeting reservations.
International customers may contact their local United Reservation Desk.

 

Mitigation of Relevant Financial Relationships

This UCSF continuing education activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

UCSF adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including content planners, reviewers, authors, presenters, moderators, panelists, or others are required to disclose all financial relationships with ineligible entities. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Commercial Support

We welcome the support of this activity in the form of an educational grant. UCSF accepts unrestricted educational grants and commercial support for continuing education activities sponsored by UCSF. Funds should be directed to the Office of CME with a fully executed agreement, signed by both a representative of UCSF CME and the funder, outlining uses of the financial support and specifically agreeing to abide to the ACCME’s Standards for Integrity and Independence. Questions concerning financial support should be directed to the Manager of Finance or the Director.

View the full Management of Commercial Support of UCSF CME policy

Download a copy of UCSF’s payment information: UCSF W9

For information about commercial support opportunities, please contact: [email protected] 

EXHIBITORS WELCOME!

Availability is limited and registration is a 2-step process this year - you must complete both of the steps to secure your space. 

The formal letter of request can be found here and the course agenda can be found here. The W9 can be found at the bottom of this page. 

1. Please download and email a signed copy of the Exhibitor Agreement to [email protected].

2. Please find our exhibitor packages below and click the Exhibit at this Event button at the bottom of the page to register. Please Note: You will need to create an account with CloudCME if you haven't already.

---

---

---

---

Term & Conditions

UCSF Office of Continuing Medical Education reserves the right to deny any application. UCSF OCME will acknowledge exhibitor(s) support in course materials as permissible by the ACCME Standards for Integrity and Independence in Accredited Continuing Education. 

The exhibitor acknowledges that conducting marketing or promotional activities in any conference area except for their assigned exhibit space is prohibited. Exhibitors/Vendors may not engage in sales, promotional activities, or distribute product-specific advertisements while in the designated location of the CME activity. CME activity space includes, but is not limited to, lecture halls, breakout rooms, and laboratory areas. 

Exhibitors and UCSF OCME agree to abide by the ACCME Standards for Integrity and Independence in Accredited CE. Any actions that are not in accordance with the above-stated policies may result in the removal of the exhibiting company and its representatives from the conference site, in which case no refund of exhibit fees will be allowed. 

---

Payment Deadline & Late Fee Policy

Exhibitor payment is due in full by the deadline listed on program materials (webpage and exhibitor agreement form). A $500 late fee will apply to any payments received after the posted deadline. 

To avoid a late fee and ensure participation, proof of payment (such as a check copy, electronic payment confirmation, or remittance advice) must be submitted by the deadline. 

Please note that exhibit placement and promotional benefits are not guaranteed until full payment and proof of payment are received. 

---

Cancellation Policy

There are no refunds for cancellations of exhibit registrations. 

Payment must be received prior to the event. 

Download a copy of UCSF’s payment information: UCSF W9 

For information about commercial support opportunities, please contact:  [email protected]

---

W9 Form Exhibit at this Event